Introduction: In 2020, Oregon became the first US state to legalize state-regulated psilocybin services. This study aims to examine: 1) the clinical and demographic characteristics, 2) psilocybin use motivations, and 3) differences in preparedness among patients seeking care in a Oregon- based pilot consult service specializing in psilocybin risk reduction. Methods: This retrospective chart...
There has been growing public and research interest in the use of psychedelics, particularly psilocybin. There is limited data on psilocybin use patterns, motivations for use, safety, and efficacy in older adults (>or= 60 years old) as older adults tend to be excluded from clinical trials. However, older adults may seek out psilocybin through state-regulated or naturalistic settings for...
Data from the Open Psychedelic Evaluation Nexus (OPEN), which runs an ongoing single-arm prospective longitudinal cohort study of safety and outcomes for individuals receiving state-regulated psilocybin services.
New legal frameworks for supervised psychedelic services are emerging, with Oregon and Colorado implementing programs to train and license psilocybin facilitators. This study describes Oregon's early psilocybin facilitator workforce and assesses state-approved training programs. The Open Psychedelic Evaluation Nexus (OPEN) reviewed Oregon Health Authority-approved training programs and surveyed...
Background: Voter initiatives in Oregon and Colorado authorize legal frameworks for supervised psilocybin services, but no measures monitor safety or outcomes. Aims: To develop core measures of best practices. Methods: A three-phase e-Delphi process recruited 36 experts with 5 or more years’ experience facilitating psilocybin experiences in various contexts (e.g., ceremonial settings,...